Investor Ideas Podcast Corner; Dr. Sarath Malepati, Creator of the EZC Pak Talks about the Growing Antibiotic
Resistance Crisis
Point
Roberts, WA, Delta BC -April 26, 2017 – Investorideas.com, a global news source
covering biotech and LOHAS, releases a
new Podcast interview with Dr. Sarath Malepati, a leading expert and
creator of the new over the counter supplement EZC Pak https://www.ezcpak.com/ which is the first physician formulated
immune support pack designed to reduce inappropriate antibiotic use.
Dr. Sarath Malepati- creator of EZC Pak
Investorideas.com
podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.
About Investorideas.com - News that Inspires Big Ideas
Investorideas.com
is a meeting place for global investors, featuring news, stock directories,
video, podcasts, company profiles, interviews and more in leading sectors.
Sectors we cover in include tech, bitcoin and
blockchain , biotech, mining, energy, renewable energy, water stocks, marijuana
and hemp stocks, food and beverage (including organic and LOHAS, wine), defense
and security including biometrics, Latin America, sports, entertainment, luxury
brands and gaming.
The Investorideas.com content portfolio goes beyond
the www.investorideas.com site to include 12 blogs on Blogger.com, 7
Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com,
all featuring Investorideas.com news and content.
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers.
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors
must adhere to regulations of each country.
Contact
Investorideas.com
800-665-0411
BiotechIndustryStocks.com -
investing ideas in biotechnology stocks, medical technology and life sciences
No comments:
Post a Comment